BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 21355078)

  • 1. Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma.
    Frigola X; Inman BA; Lohse CM; Krco CJ; Cheville JC; Thompson RH; Leibovich B; Blute ML; Dong H; Kwon ED
    Clin Cancer Res; 2011 Apr; 17(7):1915-23. PubMed ID: 21355078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble B7-H1: differences in production between dendritic cells and T cells.
    Frigola X; Inman BA; Krco CJ; Liu X; Harrington SM; Bulur PA; Dietz AB; Dong H; Kwon ED
    Immunol Lett; 2012 Feb; 142(1-2):78-82. PubMed ID: 22138406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma.
    Krambeck AE; Dong H; Thompson RH; Kuntz SM; Lohse CM; Leibovich BC; Blute ML; Sebo TJ; Cheville JC; Parker AS; Kwon ED
    Clin Cancer Res; 2007 Mar; 13(6):1749-56. PubMed ID: 17363528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.
    Thompson RH; Kuntz SM; Leibovich BC; Dong H; Lohse CM; Webster WS; Sengupta S; Frank I; Parker AS; Zincke H; Blute ML; Sebo TJ; Cheville JC; Kwon ED
    Cancer Res; 2006 Apr; 66(7):3381-5. PubMed ID: 16585157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum.
    Zhang G; Hou J; Shi J; Yu G; Lu B; Zhang X
    Immunology; 2008 Apr; 123(4):538-46. PubMed ID: 18194267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy.
    Thompson RH; Dong H; Kwon ED
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):709s-715s. PubMed ID: 17255298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation.
    Quandt D; Jasinski-Bergner S; Müller U; Schulze B; Seliger B
    J Transl Med; 2014 May; 12():151. PubMed ID: 24885059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma.
    Thompson RH; Dong H; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Kwon ED
    Clin Cancer Res; 2007 Mar; 13(6):1757-61. PubMed ID: 17363529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of B7-H1 overexpression in kidney cancer.
    Thompson RH; Kwon ED
    Clin Genitourin Cancer; 2006 Dec; 5(3):206-11. PubMed ID: 17239274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma.
    Crispen PL; Sheinin Y; Roth TJ; Lohse CM; Kuntz SM; Frigola X; Thompson RH; Boorjian SA; Dong H; Leibovich BC; Blute ML; Kwon ED
    Clin Cancer Res; 2008 Aug; 14(16):5150-7. PubMed ID: 18694993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine.
    Webster WS; Thompson RH; Harris KJ; Frigola X; Kuntz S; Inman BA; Dong H
    J Immunol; 2007 Sep; 179(5):2860-9. PubMed ID: 17709500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.
    Thompson RH; Gillett MD; Cheville JC; Lohse CM; Dong H; Webster WS; Krejci KG; Lobo JR; Sengupta S; Chen L; Zincke H; Blute ML; Strome SE; Leibovich BC; Kwon ED
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17174-9. PubMed ID: 15569934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of serum soluble T cell regulatory molecules in clear cell renal cell carcinoma.
    Masuda A; Arai K; Nishihara D; Mizuno T; Yuki H; Kambara T; Betsunoh H; Abe H; Yashi M; Fukabori Y; Yoshida K; Kamai T
    Biomed Res Int; 2014; 2014():396064. PubMed ID: 25089268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a soluble B7-H3 (sB7-H3) spliced from the intron and analysis of sB7-H3 in the sera of patients with hepatocellular carcinoma.
    Chen W; Liu P; Wang Y; Nie W; Li Z; Xu W; Li F; Zhou Z; Zhao M; Liu H
    PLoS One; 2013; 8(10):e76965. PubMed ID: 24194851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival.
    Boorjian SA; Sheinin Y; Crispen PL; Farmer SA; Lohse CM; Kuntz SM; Leibovich BC; Kwon ED; Frank I
    Clin Cancer Res; 2008 Aug; 14(15):4800-8. PubMed ID: 18676751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinoma.
    Tatsumi T; Herrem CJ; Olson WC; Finke JH; Bukowski RM; Kinch MS; Ranieri E; Storkus WJ
    Cancer Res; 2003 Aug; 63(15):4481-9. PubMed ID: 12907621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Serum Levels of Soluble B7-H4 in Patients with Systemic Lupus Erythematosus.
    Xiao JP; Wang XR; Zhang S; Wang J; Zhang C; Wang DG
    Iran J Immunol; 2019 Mar; 16(1):43-52. PubMed ID: 30864554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma.
    Thompson RH; Gillett MD; Cheville JC; Lohse CM; Dong H; Webster WS; Chen L; Zincke H; Blute ML; Leibovich BC; Kwon ED
    Cancer; 2005 Nov; 104(10):2084-91. PubMed ID: 16208700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Expression of PD-L1 Between Sporadic and VHL-Associated Hereditary Clear-Cell Renal Cell Carcinoma and Its Correlation With Clinicopathological Features.
    Hong B; Cai L; Wang J; Liu S; Zhou J; Ma K; Zhang J; Zhou B; Peng X; Zhang N; Gong K
    Clin Genitourin Cancer; 2019 Apr; 17(2):97-104.e1. PubMed ID: 30522901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrence.
    Routh JC; Ashley RA; Sebo TJ; Lohse CM; Husmann DA; Kramer SA; Kwon ED
    J Urol; 2008 May; 179(5):1954-9; discussion 1959-60. PubMed ID: 18355839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.